Boc-L-Nle(6-OH)-OH

Boc-L-Nle(6-OH)-OH is a Boc-protected L-amino acid building block featuring a side chain extended by a hydroxyl-bearing carbon chain (6-hydroxy functionality) that provides a handle for further derivatization while maintaining a protected, nonreactive amine for stepwise coupling. The combination of a stable Boc N-terminus and a free carboxylic acid makes it well suited for peptide and peptidomimetic synthesis workflows where controlled functional-group chemistry is required. Researchers commonly select this protected amino acid when they need an additional hydroxyl-bearing side chain to tune polarity, enable orthogonal downstream transformations, or introduce an alcohol functionality into larger fragments.

1. Peptide Synthesis Building Block

Boc-L-Nle(6-OH)-OH is used as an amino acid building block for assembling peptides and peptidomimetics in fragment-based synthesis, where the Boc-protected amine supports controlled coupling into longer sequences. The presence of the hydroxyl-bearing side chain enables downstream functionalization after incorporation, allowing chemists to introduce or elaborate alcohol-containing motifs in synthetic peptides used for structure-activity relationship studies, ligand optimization, or conformational probing. This product is particularly relevant for solution-phase or protected-amino-acid workflows that rely on Boc-compatible intermediates and demand a side-chain alcohol that remains available for later chemistry rather than being masked prematurely.

2. Peptidomimetic Functionalization

Boc-L-Nle(6-OH)-OH is frequently selected for peptidomimetic development and medicinal chemistry research when an alcohol-functional side chain is needed as a polarity modulator or as a synthetic handle for derivatization. After incorporation into a peptide-like scaffold, the side-chain hydroxyl can be used to generate additional analogs through standard functional-group transformations, supporting iterative library generation for binding studies, SAR campaigns, and property tuning of synthetic ligands. The Boc-protected amino acid format helps keep the amine controlled during assembly, while the free carboxylic acid supports its use as a defined chiral unit in preparing stereochemically consistent intermediates.

3. Pharmaceutical Intermediate Development

Boc-L-Nle(6-OH)-OH serves as a practical chiral intermediate for manufacturing workflows that require an L-configured, Boc-protected amino acid with an unprotected hydroxyl-bearing side chain for later elaboration. Process and R&D chemists use it to construct more complex amino-acid-derived fragments that can feed into downstream synthesis of substituted scaffolds, including alcohol-functionalized motifs that are common in medicinal chemistry intermediates. The protected amine reduces side reactions during intermediate assembly, while the hydroxyl functionality provides a chemically meaningful site for subsequent derivatization steps in the overall route design.

4. Chiral Derivatization And Standards

Boc-L-Nle(6-OH)-OH is also used in analytical and chemical development contexts where a defined chiral amino acid derivative is required as a reference material or derivatization precursor. Its controlled protection pattern (Boc on the amino group) and the presence of a side-chain hydroxyl allow researchers to generate consistent derivatives for method development and characterization workflows that distinguish stereochemical or functional-group variants. In practice, this makes it useful for supporting reproducible analytical chemistry tasks such as preparing stereochemically defined comparison compounds or enabling standardized derivatization strategies during characterization of related amino acid derivatives and peptide fragments.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII